Infinity announces new board members, promotions
By
Associated Press
July 22, 2008
|
Infinity Pharmaceuticals Inc. said Tuesday it increased the size of its board of directors to 12 members and promoted two executives.
The company named two new members to its board of directors: Martin Babler and Ian F. Smith. Babler is president and chief executive of Talima Therapeutics Inc. a privately held drug-delivery company. Smith is an executive vice president and chief financial officer at Vertex Pharmaceuticals Inc.
Infinity promoted Michael S. Curtis to vice president of pharmaceutical development from senior director while Jeanette Kohlbrenner was promoted to senior director of human resources from director.
Shares of Infinity finished unchanged at $7.80.